Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype

DM Perez, MT Piascik, N Malik, R Gaivin and RM Graham

Department of Molecular Cardiology, Cleveland Clinic Research Institute, Ohio 44195.

Three alpha 1-adrenergic receptors (ARs) have been cloned, i.e., the alpha 1B-, alpha 1C-, and alpha 1D-ARs. Compared with the alpha 1B subtype, the alpha 1A subtype in tissue is described as being insensitive to chloroethylclonidine and sensitive to SZL-49 and having a 10-100-fold higher affinity for a number of agonists and antagonists. The alpha 1A subtype is also expressed in a variety of rat tissues (as assessed by pharmacology), with greatest abundance in the cerebral cortex, hippocampus, vas deferens, and submaxillary gland. The cloned bovine alpha 1C-AR, though having an alpha 1A-AR pharmacology, was first reported as not being expressed in any rat tissue (as determined by Northern analysis) and was therefore designated as a new subtype. We report the cloning, expression, and characterization of the rat homolog of the bovine alpha 1C-AR. Using a human alpha 1C-AR probe obtained by polymerase chain reaction screening of a neuroblastoma cell line (SK-N- MC), both exon 1 and exon 2 of the rat alpha 1C-AR gene were cloned from a rat genomic library. These two exons were spliced together and cloned into the expression vector pMT2'. Transfection into COS-1 cells and analysis of the ligand-binding profile of the expressed protein receptor using 125I-HEAT revealed a 10-100-fold higher affinity for the alpha 1-AR antagonists 5-methylurapidil, (+)-niguldipine, WB-4101, and phentolamine and the agonists oxymetazoline and methoxamine, compared with the alpha 1B-AR. This ligand-binding profile is similar to that for endogenously expressed tissue alpha 1A-ARs. In addition, the rat alpha 1C-AR was the least sensitive of the three cloned subtypes to the alkylating effects of chloroethylclonidine but was the most sensitive to the alkylating prazosin analog SZL-49, properties also observed for the tissue alpha 1A subtype. Furthermore, by three different techniques, i.e., RNase protection assays, reverse transcription- polymerase chain reaction Northern blotting, and in situ hybridization histochemistry, the rat alpha 1C-AR mRNA was localized to alpha 1A-AR- rich tissues, such as rat vas deferens, hippocampus, aorta, and submaxillary gland. Taken together, these data suggest that this receptor may actually represent the alpha 1A subtype.

Volume 46, Issue 5, pp. 823-831, 11/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. L. Hillman, V. A. Doze, and J. E. Porter {alpha}1A-Adrenergic Receptors Are Functionally Expressed by a Subpopulation of Cornu Ammonis 1 Interneurons in Rat Hippocampus J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1062 - 1068. [Abstract] [Full Text] [PDF]

				T. Shi, Z.-H. Duan, R. Papay, E. Pluskota, R. J. Gaivin, C. A. de la Motte, E. F. Plow, and D. M. Perez Novel {alpha}1-Adrenergic Receptor Signaling Pathways: Secreted Factors and Interactions with the Extracellular Matrix Mol. Pharmacol., July 1, 2006; 70(1): 129 - 142. [Abstract] [Full Text] [PDF]

				B. R. Rorabaugh, S. A. Ross, R. J. Gaivin, R. S. Papay, D. F. McCune, P. C. Simpson, and D. M. Perez {alpha}1A- but not {alpha}1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism Cardiovasc Res, February 1, 2005; 65(2): 436 - 445. [Abstract] [Full Text] [PDF]

				J. Yun, R. J. Gaivin, D. F. McCune, A. Boongird, R. S. Papay, Z. Ying, P. J. Gonzalez-Cabrera, I. Najm, and D. M. Perez Gene expression profile of neurodegeneration induced by {alpha}1B-adrenergic receptor overactivity: NMDA/GABAA dysregulation and apoptosis Brain, December 1, 2003; 126(12): 2667 - 2681. [Abstract] [Full Text] [PDF]

				I. A. Sharpe, L. Thomas, M. Loughnan, L. Motin, E. Palant, D. E. Croker, D. Alewood, S. Chen, R. M. Graham, P. F. Alewood, et al. Allosteric {alpha}1-Adrenoreceptor Antagonism by the Conopeptide {rho}-TIA J. Biol. Chem., September 5, 2003; 278(36): 34451 - 34457. [Abstract] [Full Text] [PDF]

				E. Ducza, R. Gáspár, A. Márki, P. Gyula, S. Bottka, and G. Falkay Use of Antisense Oligonucleotides to Verify the Role of the alpha 1A-Adrenergic Receptor in the Contractility of the Rat Uterus Post Partum Mol. Pharmacol., April 16, 2001; 59(5): 1235 - 1242. [Abstract] [Full Text]

				D. J. J. Waugh, R. J. Gaivin, D. S. Damron, P. A. Murray, and D. M. Perez Binding, Partial Agonism, and Potentiation of alpha 1-Adrenergic Receptor Function by Benzodiazepines: A Potential Site of Allosteric Modulation J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1164 - 1171. [Abstract] [Full Text]

				M. J. Zuscik, M. T. Piascik, and D. M. Perez Cloning, Cell-Type Specificity, and Regulatory Function of the Mouse alpha 1B-Adrenergic Receptor Promoter Mol. Pharmacol., December 1, 1999; 56(6): 1288 - 1297. [Abstract] [Full Text]

				E. E. Daniel, R. D. Brown, Y. F. Wang, A. M. Low, H. Lu-Chao, and C.-Y. Kwan alpha -Adrenoceptors in Canine Mesenteric Artery Are Predominantly 1A Subtype: Pharmacological and Immunochemical Evidence J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 671 - 679. [Abstract] [Full Text]

				S. L. Hrometz, S. E. Edelmann, D. F. McCune, J. R. Olges, R. W. Hadley, D. M. Perez, and M. T. Piascik Expression of Multiple alpha 1-Adrenoceptors on Vascular Smooth Muscle: Correlation with the Regulation of Contraction J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 452 - 463. [Abstract] [Full Text]

				J.-M. Ye and E. Q. Colquhoun Changes in Functional Expression of Alpha-1 Adrenoceptors in Hindlimb Vascular Bed of Spontaneously Hypertensive Rats and their Effects on Oxygen Consumption J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 599 - 606. [Abstract] [Full Text]

				P. J. Gonzalez-Cabrera, P. L. Iversen, M. F. Liu, M. A. Scofield, and W. B. Jeffries Selective Inhibition of alpha 1B-Adrenergic Receptor Expression and Function Using a Phosphorothioate Antisense Oligodeoxynucleotide Mol. Pharmacol., June 1, 1998; 53(6): 1034 - 1039. [Abstract] [Full Text]

				H. Yokoyama, M. Yasutake, and M. Avkiran {alpha}1-Adrenergic Stimulation of Sarcolemmal Na+-H+ Exchanger Activity in Rat Ventricular Myocytes : Evidence for Selective Mediation by the {alpha}1A-Adrenoceptor Subtype Circ. Res., June 1, 1998; 82(10): 1078 - 1085. [Abstract] [Full Text] [PDF]

				M.-M. Zhao, R. J. Gaivin, and D. M. Perez The Third Extracellular Loop of the beta 2-Adrenergic Receptor Can Modulate Receptor/G Protein Affinity Mol. Pharmacol., March 1, 1998; 53(3): 524 - 529. [Abstract] [Full Text]

				Y. Ruan, H. Kan, J.-H. Parmentier, S. Fatima, L. F. Allen, and K. U. Malik Alpha-1A Adrenergic Receptor Stimulation with Phenylephrine Promotes Arachidonic Acid Release by Activation of Phospholipase D in Rat-1 Fibroblasts: Inhibition by Protein Kinase A J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 576 - 585. [Abstract] [Full Text]

				A. Hirasawa, T. Sugawara, T. Awaji, K. Tsumaya, H. Ito, and G. Tsujimoto Subtype-Specific Differences in Subcellular Localization of alpha 1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface alpha 1-Adrenoceptors Irrespective of the Subtype Mol. Pharmacol., November 1, 1997; 52(5): 764 - 770. [Abstract] [Full Text]

				E. Thorin, S. M. Shreeve, N. Thorin-Trescases, and J. A. Bevan Reversal of Endothelin-1 Release by Stimulation of Endothelial {alpha}2-Adrenoceptor Contributes to Cerebral Vasorelaxation Hypertension, October 1, 1997; 30(4): 830 - 836. [Abstract] [Full Text]

				H.-T. Li, C. S. Long, M. O. Gray, D. G. Rokosh, N. Y. Honbo, and J. S. Karliner Cross Talk Between Angiotensin AT1 and {alpha}1-Adrenergic Receptors : Angiotensin II Downregulates {alpha}1a-Adrenergic Receptor Subtype mRNA and Density in Neonatal Rat Cardiac Myocytes Circ. Res., September 19, 1997; 81(3): 396 - 403. [Abstract] [Full Text]

				X. Xin, N. Yang, A. D. Eckhart, and J. E. Faber alpha 1D-Adrenergic Receptors and Mitogen-Activated Protein Kinase Mediate Increased Protein Synthesis by Arterial Smooth Muscle Mol. Pharmacol., May 1, 1997; 51(5): 764 - 775. [Abstract] [Full Text]

				K. Taguchi, M. Saitoh, S. Sato, M. Asano, and M. C. Michel Effects of Tamsulosin Metabolites at Alpha-1 Adrenoceptor Subtypes J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 1 - 5. [Abstract] [Full Text]

				S. Chen, F. Lin, S. Iismaa, K. N. Lee, P. J. Birckbichler, and R. M. Graham alpha 1-Adrenergic Receptor Signaling via Gh Is Subtype Specific and Independent of Its Transglutaminase Activity J. Biol. Chem., December 13, 1996; 271(50): 32385 - 32391. [Abstract] [Full Text] [PDF]

				J. E. Porter, J. Hwa, and D. M. Perez Activation of the alpha 1b-Adrenergic Receptor Is Initiated by Disruption of an Interhelical Salt Bridge Constraint J. Biol. Chem., November 8, 1996; 271(45): 28318 - 28323. [Abstract] [Full Text] [PDF]

				R. M. Graham, D. M. Perez, J. Hwa, and M. T. Piascik {alpha}1-Adrenergic Receptor Subtypes : Molecular Structure, Function, and Signaling Circ. Res., May 1, 1996; 78(5): 737 - 749. [Full Text]

				J. Hwa and D. M. Perez The Unique Nature of the Serine Interactions for alpha(1)-Adrenergic Receptor Agonist Binding and Activation J. Biol. Chem., March 15, 1996; 271(11): 6322 - 6327. [Abstract] [Full Text] [PDF]

				D. G. Rokosh, A. F. R. Stewart, K. C. Chang, B. A. Bailey, J. S. Karliner, S. A. Camacho, C. S. Long, and P. C. Simpson alpha(1)-Adrenergic Receptor Subtype mRNAs Are Differentially Regulated by alpha(1)-Adrenergic and Other Hypertrophic Stimuli in Cardiac Myocytes in Culture and In Vivo J. Biol. Chem., March 8, 1996; 271(10): 5839 - 5843. [Abstract] [Full Text] [PDF]

				J. Hwa, R. M. Graham, and D. M. Perez Identification of Critical Determinants of alpha(1)-Adrenergic Receptor Subtype Selective Agonist Binding J. Biol. Chem., September 29, 1995; 270(39): 23189 - 23195. [Abstract] [Full Text] [PDF]

				H.-T. Li, C. S. Long, D. G. Rokosh, N. Y. Honbo, and J. S. Karliner Chronic Hypoxia Differentially Regulates {alpha}1-Adrenergic Receptor Subtype mRNAs and Inhibits {alpha}1-Adrenergic Receptor–Stimulated Cardiac Hypertrophy and Signaling Circulation, August 15, 1995; 92(4): 918 - 925. [Abstract] [Full Text]

				M. J. Zuscik, D. Chalothorn, D. Hellard, C. Deighan, A. McGee, C. J. Daly, D. J. J. Waugh, S. A. Ross, R. J. Gaivin, A. J. Morehead, et al. Hypotension, Autonomic Failure, and Cardiac Hypertrophy in Transgenic Mice Overexpressing the alpha 1B-Adrenergic Receptor J. Biol. Chem., April 20, 2001; 276(17): 13738 - 13743. [Abstract] [Full Text] [PDF]

				D. J. J. Waugh, R. J. Gaivin, M. J. Zuscik, P. Gonzalez-Cabrera, S. A. Ross, J. Yun, and D. M. Perez Phe-308 and Phe-312 in Transmembrane Domain 7 Are Major Sites of alpha 1-Adrenergic Receptor Antagonist Binding. IMIDAZOLINE AGONISTS BIND LIKE ANTAGONISTS J. Biol. Chem., June 29, 2001; 276(27): 25366 - 25371. [Abstract] [Full Text] [PDF]